We’re 3 for 3 in orbit this October. This time, it’s space drugs. W-7 carries pharmaceutical hardware and a promising new type of cancer medicine known as a protein degrader. Microgravity will help overcome one of its biggest limitations: poor solubility.
Varda is designing and building the infrastructure needed to make low Earth orbit accessible, from in-orbit production equipment to reliable reentry capsules.


